Smart software aims to improve liver cancer ablation

NCT ID NCT07226869

Recruiting now Disease control Sponsor: NE Scientific INC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a computer guidance software can help doctors more completely destroy liver tumors during microwave ablation. About 84 adults with liver cancer (HCC) will have the procedure with the software's assistance, and their outcomes will be compared to historical data. The goal is to see if the software reduces incomplete treatments and tumor recurrence over two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Computer-assisted image-processing software for guiding microwave ablation
What this could lead to: If successful, this could make liver tumor ablation more precise, reducing the chance of leftover cancer and lowering recurrence rates.
What could go wrong: This is a small, early-stage trial comparing results to past patients, not a randomized control group. The software may not significantly improve outcomes, and risks from the ablation procedure itself remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA (HCC)

Contacts and locations

Locations

Dartmouth HItchcock Medical Center
RECRUITING

Lebanon, New Hampshire, 03756, United States
Massachusetts General Hospital
NOT_YET_RECRUITING

Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.